Abstract

Dialysis is the most common therapy for patients afflicted with chronic kidney failure. Currently, little is known about the relationship between the timing of dialysis initiation and the therapy's cost and effectiveness. This paper examines the cost-effective initiation of dialysis and compares standard initiation criteria from the clinical literature to computationally derived strategies. Comparisons make use of a simulation model that integrates submodels of disease progression, hospitalization, transplantation, cost, and quality of life. The simulation model is also used by an approximate dynamic programming (ADP) algorithm to derive approximately optimal strategies that maximize patient welfare. Patient welfare is measured from the society's perspective and is defined as the product of the expected discounted quality-adjusted life years (QALYs) and a “value-of-life” parameter, minus the expected total discounted medical expenditures. Also considered is an alternative formulation in which the goal is to minimize the expected total discounted medical expenditures without affecting patient QALYs relative to current medical practice. Numerical results show that: (i) standard early initiation strategies, where once started on dialysis patients are kept on a fixed weekly program, have a limited potential, and (ii) early dialysis at an incrementally increasing dose customized to each patient can yield a significant cost advantage. These findings demonstrate computationally intensive models of disease progression, and therapy effectiveness can identify novel strategies for managing expensive medical therapies and a more efficient use of scarce health-care resources.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.